Acorda Therapeutics is a biotechnology company based in Raleigh, NC, dedicated to developing and marketing therapies for individuals with nervous system disorders. With a focus on improving the lives of millions of people, Acorda conducts extensive research, product development, and commercialization in the field of nervous systems research.
Under the leadership of CEO Ron Cohen, Acorda maintains an open dialogue with patients, caregivers, healthcare professionals, and investors, fostering a corporate culture that prioritizes innovation and making a difference in people's lives. Their product portfolio includes ARCUS Technology, AMPYRA, INBRIJA, and other life-changing therapies.
Generated from the website